Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role ofMPLpolymorphisms-Reference-Cited by-同舟云学术

Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role ofMPLpolymorphisms

Published:2012-12-29 Issue:1 Volume:161 Page:142-144
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Polverelli Nicola¹,Palandri Francesca¹,Iacobucci Ilaria¹,Catani Lucia¹,Martinelli Giovanni¹,Vianelli Nicola¹

Affiliation:

1. Department of Haematology and Clinical Oncology “L. and A. Seràgnoli”, S.Orsola-Malpighi Hospital; University of Bologna; Bologna; Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12186/fullpdf

Reference8 articles.

1. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations;Aoki;Journal of Clinical Pharmacy and Therapeutics,2012

2. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP;Bussel;Blood,2009

3. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study;Cheng;Lancet,2011

4. Comparative analyses of the small molecule thrombopoietin receptor agonist Eltrombopag and thrombopoietin on in vitro platelet function;Erhardt;Experimental Hematolology,2009

5. Eltrombopag;Garnock-Jones;Drugs,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE‐related immune thrombocytopenia;Pediatric Blood & Cancer;2024-02-13

2. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives;Annals of Hematology;2022-02-24

3. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia;Expert Review of Hematology;2020-11-30

4. The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature;J RES PHARM PRACT;2018

5. Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review;BLOOD TRANSFUS-ITALY;2018